Compared with female patients with NSCLC, the odds of carrying ALK rearrangements was reduced by 28% (95% CI: 0.58–0.90; P = 0.004) in males (I2 = 51%) (Figure 3). This evidence concerns the gene ALK and non-small cell lung carcinoma.